Celltrion Archives -

COVID antibodies from Roche, Celltrion backed for approval in EU

Phil Taylor antibody, Celltrion, CHMP, coronavirus, COVID-19, Regeneron, Roche 0 Comment

The EMA’s human medicines committee has recommended approval of Roche’s Ronapreve and Celltrion’s Regkirona for use in COVID-19,

COVID antibodies from Roche, Celltrion backed for approval in EU

https://pharmaphorum.com/news/first-covid-antibodies-from-roche-celltrion-backed-in-eu/

R&D/ Views & Analysis/ Views and analysis

COVID-19: Celltrion’s therapeutic option

Catherine Longworth Celltrion, COVID-19, CT-P59, ema 0 Comment

In just over a year, Celltrion Healthcare says it has identified and delivered a potential treatment for COVID-19.

COVID-19: Celltrion’s therapeutic option

https://pharmaphorum.com/r-d/covid-19-providing-a-therapeutic-option/

Market Access/ News/ News

CHMP backs Celltrion’s regdanvimab antibody for COVID-19

Phil Taylor Celltrion, CHMP, coronavirus, COVID-19, Diurnal, ema, EU, Janssen, Johnson & Johnson, Verastem 0 Comment

The EU looks set to approve emergency use of a third antibody therapy for COVID-19 after its human

CHMP backs Celltrion’s regdanvimab antibody for COVID-19

https://pharmaphorum.com/news/chmp-backs-celltrions-regdanvimab-antibody-for-covid-19/

News/ News/ R&D

Celltrion closes in on COVID-19 antibody market after trial success

Richard Staines Celltrion, COVID-19, Eli Lilly, R&D 0 Comment

South Korea’s Celltrion has announced encouraging top-line results for its potential antibody therapy for COVID-19, with the first

Celltrion closes in on COVID-19 antibody market after trial success

https://pharmaphorum.com/news/celltrion-closes-in-on-covid-19-antibody-market-after-trial-success/

News

Celltrion buys drug portfolio from Takeda, ventures into chronic diseases

Richard Staines Celltrion, chronic diseases, Diabetes, hypertension, M&A, Takeda 0 Comment

South Korea’s Celltrion has made its first major acquisition, buying a portfolio of drugs including diabetes and hypertension drugs from

Celltrion buys drug portfolio from Takeda, ventures into chronic diseases

https://pharmaphorum.com/news/celltrion-ventures-into-chronic-diseases-with-takeda-portfolio-buy/

News/ News/ R&D

Celltrion trials infliximab biosimilar in recovering COVID-19 patients

Richard Staines Celltrion, coronavirus, COVID-19, R&D 0 Comment

South Korea’s Celltrion Healthcare has begun a UK trial of its infliximab biosimilar to see if the drug can accelerate recovery

Celltrion trials infliximab biosimilar in recovering COVID-19 patients

https://pharmaphorum.com/news/celltrion-trials-infliximab-biosimilar-in-recovering-covid-19-patients/

Charities bankroll coronavirus drug hunt as outbreak hits economies

News/ News/ R&D

Celltrion to develop coronavirus antibody and fast test

Richard Staines antiviral, Celltrion, coronavirus, diagnostics, infectious diseases, R&D 0 Comment

South Korea’s Celltrion has joined the many pharma companies fighting the COVID-19 coronavirus outbreak, saying it is working

Celltrion to develop coronavirus antibody and fast test

https://pharmaphorum.com/news/celltrion-antibody-and-fast-test/

Market Access/ News/ News

Celltrion plans to launch a biosimilar each year for next decade

Richard Staines biosimilar, Celltrion, market access 0 Comment

There are plenty of pharma companies outlining their strategies for the new decade this week at the JP

Celltrion plans to launch a biosimilar each year for next decade

https://pharmaphorum.com/news/celltrion-plans-to-launch-a-biosimilar-each-year-for-next-decade/

Market Access/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis

Celltrion gears up for subcutaneous infliximab launch in Europe

Richard Staines biosimilars, Celltrion, IBD, infliximab, Rheumatoid arthritis 0 Comment

Celltrion Healthcare’s subcutaneous (SC) formulation of its infliximab biosimilar, codenamed CT-P13 SC, looks set to launch in Europe

Celltrion gears up for subcutaneous infliximab launch in Europe

https://pharmaphorum.com/views-analysis-market-access/celltrion-gears-up-for-subcutaneous-infliximab-launch-in-europe/

Trending

Celltrion

Login